`
Pharmaceutical Technology E-Alert:
Having trouble viewing this e-mail? Click here.
  Pharmaceutical Technology Europe E-Alert
 
14 December 2012
IN THIS ISSUE
News
Regulatory Briefs
lIndustry Briefs
Webcasts
Events
About Us
Top Pharma Stories for November
Extractables and leachables are the focus of this month’s issue of PTE Digital. E&Ls can lead to quality defects and more, and must be considered by pharma manufacturers. Other top stories this issue include quality by design, biosimilar mAbs and Alzheimer’s Disease. More...
 
Growing Area of Concern for Pharma Companies
Extractables and leachables are a growing area of concern for pharmaceutical regulators. Our roundtable of industry experts looks at the common types of E&Ls and how pharmaceutical manufacturers are tackling the challenges with analytical testing technologies More...
 
Europe's Alzheimer's R&D Crisis
The pharmaceutical industry is under pressure to deliver new therapies for Alzheimer’s disease, but regulatory bureaucracy in Europe coupled with the demand for lower-priced medicines continues to hinder efforts in innovation. More...
 
EU Sets Guidelines for Biosimilar Monoclonal Antibodies
The  European Medicines Agency has released a guideline on biosimilar monoclonal  antibodies (mAbs) that lays down general principles for nonclinical and clinical studies on the  differences between biosimilar and reference mAbs. More...
 
Pharma News Roundup
If you’ve missed out on some of the top pharma news stories recently then our news roundup will update you. Highlights include Novasep’s chromatography plant, Europe’s first facility for cell-based therapeutics, and more. More...
 
Pharma News Roundup
If you’ve missed out on some of the top pharma news stories recently then our news roundup will update you. Highlights include Novasep’s chromatography plant, Europe’s first facility for cell-based therapeutics, and more. More...
 
Pharma News Roundup
If you’ve missed out on some of the top pharma news stories recently then our news roundup will update you. Highlights include Novasep’s chromatography plant, Europe’s first facility for cell-based therapeutics, and more. More...
 
Pharma News Roundup
If you’ve missed out on some of the top pharma news stories recently then our news roundup will update you. Highlights include Novasep’s chromatography plant, Europe’s first facility for cell-based therapeutics, and more. More...

Eliminate Ghost Peaks in UHPLC
  • Shimadzu has introduced the Ghost Trap DS-HP Series Columns.
  • Shimadzu has introduced the Ghost Trap DS-HP Series Columns.
  • the Ghost Trap™ DS-HP
  • Shimadzu has introduced the Ghost Trap DS-HP Series Columns.
  • Series Columns which are designed.
Read more
Eliminate Ghost Peaks in UHPLC
  • Shimadzu has introduced the Ghost Trap DS-HP Series Columns.
  • Shimadzu has introduced the Ghost Trap DS-HP Series Columns.
  • the Ghost Trap™ DS-HP
  • Shimadzu has introduced the Ghost Trap DS-HP Series Columns.
  • Series Columns which are designed.
Read more

Eliminate Ghost Peaks in UHPLC
Shimadzu has introduced the Ghost Trap™ DS-HP Series Columns which are designed to remove impurities from the solvent and system, enabling highly sensitive and reliable analysis.
Read more
Eliminate Ghost Peaks in UHPLC
Shimadzu has introduced the Ghost Trap™ DS-HP Series Columns which are designed to remove impurities from the solvent and system, enabling highly sensitive and reliable analysis.
Read more

Eliminate Ghost Peaks in UHPLC
Shimadzu has introduced the Ghost Trap™ DS-HP Series Columns which are designed to remove impurities from the solvent and system, enabling highly sensitive and reliable analysis.
Read more
Eliminate Ghost Peaks in UHPLC
Shimadzu has introduced the Ghost Trap™ DS-HP Series Columns which are designed to remove impurities from the solvent and system, enabling highly sensitive and reliable analysis.
Read more

Eliminate Ghost Peaks in UHPLC
Shimadzu has introduced the Ghost Trap™ DS-HP Series Columns which are designed to remove impurities from the solvent and system, enabling highly sensitive and reliable analysis.
Read more
Eliminate Ghost Peaks in UHPLC
Shimadzu has introduced the Ghost Trap™ DS-HP Series Columns which are designed to remove impurities from the solvent and system, enabling highly sensitive and reliable analysis.
Read more

Survey
Compared with 2011, has your company attended more or less industry trade shows in 2012?
 
More 17%
 
 
Less 64%
     
 
About the same 19%

This week we would like to know...

Do you think more regulatory attention is needed in the area of tablet splitting?

Click here to vote

Contact Us
Click here to contact editorial.

Click here to contact sales.


Latest blog posts
ABPI Issues Call to Improve UK Pharma
Will FDA Gain More Oversight Over Compounders
More blog posts

Upcoming events
Asia Pharma R&D Outsourcing Congress (26–27 November | UK)
World Drug Manufacturing Summit (26–28 November | Germany)
Pharma Integrates 2012 (28–29 November | UK)
More events

Contact Us

Click here to contact editorial.

Click here to contact sales.